These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Soluble hemoglobin-haptoglobin scavenger receptor CD163 as a lineage-specific marker in the reactive hemophagocytic syndrome. Schaer DJ; Schleiffenbaum B; Kurrer M; Imhof A; Bächli E; Fehr J; Moller HJ; Moestrup SK; Schaffner A Eur J Haematol; 2005 Jan; 74(1):6-10. PubMed ID: 15613100 [TBL] [Abstract][Full Text] [Related]
6. Serum markers of macrophage activation in pre-eclampsia: no predictive value of soluble CD163 and neopterin. Kronborg CS; Knudsen UB; Moestrup SK; Allen J; Vittinghus E; Møller HJ Acta Obstet Gynecol Scand; 2007; 86(9):1041-6. PubMed ID: 17712642 [TBL] [Abstract][Full Text] [Related]
7. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Bleesing J; Prada A; Siegel DM; Villanueva J; Olson J; Ilowite NT; Brunner HI; Griffin T; Graham TB; Sherry DD; Passo MH; Ramanan AV; Filipovich A; Grom AA Arthritis Rheum; 2007 Mar; 56(3):965-71. PubMed ID: 17328073 [TBL] [Abstract][Full Text] [Related]
8. CD163 as a valuable diagnostic and prognostic biomarker of sepsis-associated hemophagocytic lymphohistiocytosis in critically ill children. Cui Y; Xiong X; Ren Y; Wang F; Wang C; Zhang Y Pediatr Blood Cancer; 2019 Oct; 66(10):e27909. PubMed ID: 31298489 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of soluble CD163 as a marker of inflammation in psoriasis. Feighery C; Dunne J; Bingham EA; Feighery CF Clin Exp Dermatol; 2011 Mar; 36(2):201-3. PubMed ID: 21323937 [TBL] [Abstract][Full Text] [Related]
10. Plasma level of the macrophage-derived soluble CD163 is increased and positively correlates with severity in Gaucher's disease. Møller HJ; de Fost M; Aerts H; Hollak C; Moestrup SK Eur J Haematol; 2004 Feb; 72(2):135-9. PubMed ID: 14962251 [TBL] [Abstract][Full Text] [Related]
11. The macrophage activation marker sMR as a diagnostic and prognostic marker in patients with acute infectious disease with or without sepsis. Marie Relster M; Gaini S; Møller HJ; Johansen IS; Pedersen C Scand J Clin Lab Invest; 2018 May; 78(3):180-186. PubMed ID: 29383956 [TBL] [Abstract][Full Text] [Related]
12. Human monocyte CD163 expression inversely correlates with soluble CD163 plasma levels. Davis BH; Zarev PV Cytometry B Clin Cytom; 2005 Jan; 63(1):16-22. PubMed ID: 15624200 [TBL] [Abstract][Full Text] [Related]
13. Soluble CD163, a unique biomarker to evaluate the disease activity, exhibits macrophage activation in systemic juvenile idiopathic arthritis. Sakumura N; Shimizu M; Mizuta M; Inoue N; Nakagishi Y; Yachie A Cytokine; 2018 Oct; 110():459-465. PubMed ID: 29801971 [TBL] [Abstract][Full Text] [Related]
14. Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD. Axelsson J; Møller HJ; Witasp A; Qureshi AR; Carrero JJ; Heimbürger O; Bárány P; Alvestrand A; Lindholm B; Moestrup SK; Stenvinkel P Am J Kidney Dis; 2006 Dec; 48(6):916-25. PubMed ID: 17162146 [TBL] [Abstract][Full Text] [Related]
15. Neutrophil and monocyte activation markers have prognostic impact in disseminated intravascular coagulation: in vitro effect of thrombin on monocyte CD163 shedding. Chung S; Kim JE; Park S; Han KS; Kim HK Thromb Res; 2011 May; 127(5):450-6. PubMed ID: 21255822 [TBL] [Abstract][Full Text] [Related]